Company Long-Term Indebtedness: Ginkgo Bioworks (DNA)

Graphic logo of Ginkgo Bioworks (DNA)

Ginkgo Bioworks Holdings (DNA) management aims to transform synthetic biology by establishing a global tech hub and expanding its patent portfolio. However, super-voting shares and concerns regarding metric transparency create risks, requiring these visionaries to prove their monetization capabilities. The business is pivoting toward cloud AI services and licensing to reduce laboratory expenditures. Debt stands at 0.36. The market trend for long-term liabilities is illustrated in the chart below.

DNA Ginkgo Bioworks Holdings, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/31/2026

ginkgobioworks.com - analytical breakdowns and key metrics (DNA)

- stock value and consensus price forecast:
Market Chart Ginkgo Bioworks Corp.|DNA - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Ginkgo Bioworks|DNA - Total Company Value
- balance sheet net asset value indicators:
Book Value per Share Ginkgo Bioworks|DNA - Book Capitalization|Market Value to Equity Ratio ginkgobioworks.com|DNA - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Capital Ginkgo Bioworks Holdings|DNA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Ginkgo Bioworks|DNA - Company Aggregate Debts|Debt to Book Capitalization Ratio Ginkgo Bioworks|DNA - Company Long-Term Debts|Short-Term Debt Volume Ginkgo Bioworks|Immediate Liquidity ginkgobioworks.com
- business earnings and investment ratios data:
DNA - Net Income
Summary company analytics:Ginkgo Bioworks Inc (DNA)
Manufactured product of ginkgobioworks.com

Scaling the cell programming cloud foundry requires significant capital expenditures, which is reflected in the current level of long-term financial debt for Ginkgo Bioworks Holdings (DNA) on the GURU.Markets platform. This indicator aggregates all obligations with maturities exceeding twelve months, allowing investors to differentiate the strategic development of the Ginkgo Bioworks Holdings (DNA) ecosystem from operational stagnation or a critical debt burden.

Who Ginkgo Bioworks Holdings competes with

Long-Term Debt Volume nvidia.com (NVDA)|CRWV - Company Long-Term Debt|NBIS (group.nebius.com) - Company Long-Term Indebtedness|SoundHound Inc. (SOUN) - Company Long-Term Debt|Zeta Global Holdings Corp. (ZETA) - Company Long-Term Debts|PGY (Pagaya Technologies) - Company Long-Term Debts|AI - Long-Term Indebtedness|Company Long-Term Debt Recursion Corp (RXRX)|RZLV - Long-Term Debt|Super X AI Corp - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings CRNC|Palladyne AI Corp. - Company Long-Term Debts|VERI: Company Long-Term Debt|MIMI: Company Long-Term Debts|MLGO - Long-Term Debt Volume|Company Long-Term Debt Helport AI Ltd.|Long-Term Debt LivePerson Inc. LPSN|Company Long-Term Liabilities QUIK (QuickLogic Corporation)|Company Long-Term Liabilities system1.com SST|Company Long-Term Debt Datavault AI DVLT|Ruanyun Edai (RYET) - Long-Term Debt|WETO - Company Long-Term Debt|Company Long-Term Loans and Borrowings MCRP (Micropolis Corp)|cyngn.com (CYN) - Company Long-Term Debt|Connexa Sports Technologies Inc. (YYAI) - Company Long-Term Debts|Company Long-Term Debt MicroCloud Hologram, Inc.|MultiSensor AI Holdings Inc. (MSAI) - Long-Term Debt Volume|Company Long-Term Liabilities EVAX (Evaxion Biotech Corp)|AIXI (Xiaoi Corporation) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CXAI (CXApp Inc.)|Company Long-Term Loans and Borrowings BNAI|GXAI - Company Long-Term Debt|Long-Term Debt Evogene Ltd.|infobird.com (IFBD) - Company Long-Term Debt|TAOP (China Information Technology) - Company Long-Term Debt|VSAI (VERSES AI Inc.) - Company Long-Term Debts|Company Long-Term Indebtedness EXAI (Exscientia Inc.)|Company Long-Term Debts FOXO|Long-Term Debt Volume vocodia.com|Company Long-Term Debt Zapata Computing Holdings Inc. ZPTA